Published • loading... • Updated
Biocodex Plans €15m Beauvais Manufacturing Platform
Summary by Industrial News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Biocodex plans €15m Beauvais manufacturing platform
Biocodex plans to invest €15 million in anaerobic pharmaceutical manufacturing infrastructure at its Beauvais site in France, under a partnership with Belgian biotechnology company MRM Health intended to support the development and eventual commercial production of live biotherapeutic medicines. The investment will establish a specialist production platform inside an existing 900m² building. Biocodex will finance, build, own and operate the faci…
The Biocodex pharmaceutical group is embarking on the production of living biotherapeutic products, an emerging market. With its expertise in microbiology, it intends to release the first clinical batches by 2028.
·Paris, France
Read Full ArticleCoverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
